<DOC>
	<DOC>NCT02939430</DOC>
	<brief_summary>Sugammadex is new drug that is used for reversal of rocuronium induced muscle relaxation. benefits of reversal of neuromuscular blockade appears to be of great value in living donor liver transplant recipients. However, Few Clinical reports have investigated the anticoagulant effect of sugammadex. In this study, effects of sugammadex on bleeding profile of living donor liver transplantation will be investigated.</brief_summary>
	<brief_title>Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Atropine</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<criteria>all candidates for living donor liver transplantation massive intraoperative bleeding manifestations of early graft dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>